Autophagy-active beclin-1 correlates with favourable clinical outcome in non-Hodgkin lymphomas

Modern Pathology

Volumn 23, Issue 7, 2010, Pages 937-950

  Nicotra, Giuseppina ^a,b   Mercalli, Francesca ^b   Peracchio, Claudia ^a   Castino, Roberta ^a   Follo, Carlo ^a   Valente, Guido ^b   Isidoro, Ciro ^a  

^a Laboratorio di Patologia Molecolare Del   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

autophagy; bcl 2; beclin 1; LC3; prognosis; tumour marker

Indexed keywords

BECLIN 1; PROTEIN BCL 2; APOPTOSIS REGULATORY PROTEIN; BECN1 PROTEIN, HUMAN; MEMBRANE PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; AUTOPHAGY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CELL VACUOLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; LYMPHOCYTOMA; LYMPHOMA CELL; MAJOR CLINICAL STUDY; MALE; MARGINAL ZONE LYMPHOMA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME; BIOSYNTHESIS; FLUORESCENT ANTIBODY TECHNIQUE; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; VERY ELDERLY; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; BLOTTING, WESTERN; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPHOMA, NON-HODGKIN; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TUMOR MARKERS, BIOLOGICAL; KAPLAN-MEIER ESTIMATE;

EID: 77954242444     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.80     Document Type: Article

References (43)

1. Gao X, Zacharek A, Salkowski A, et al. Los of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. Cancer Res 1995;55:1002-1005.
2. Futreal PA, Söderkvist P, Marks JR, et al. Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Cancer Res 1992;52:2624-2627.
3. Saito H, Inazawa J, Saito S, et al. Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors. Cancer Res 1993;53:3382-3385.
4. Russell SE, Hickey GI, Lowry WS, et al. Allele loss from chromosome 17 in ovarian cancer. Oncogene 1990;5:1581-1583.
5. Eccles DM, Russell SE, Haites NE, et al. Early loss of heterozygosity on 17q in ovarian cancer. The Abe Ovarian Cancer Genetics Group. Oncogene 1992;7:2069-2072.
6. Yue Z, Jin S, Yang C, et al. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA 2003;100:15077-15082.
7. Qu X, Yu J, Bhagat G, et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 2003;112:1809-1820.
8. Liang XH, Kleeman LK, Jiang HH, et al. Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J Virol 1998;72:8586-8596.
9. Itakura E, Kishi C, Inoue K, et al. Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. Mol Biol Cell 2008;19:5360-5372.
10. Zhong Y, Wang QJ, Li X, et al. Distinct regulation of autophagic activity by Atg14L and Rubicon associated with beclin1-phosphatidylinositol-3-kinase complex. Nat Cell Biol 2009;11:468-476.
11. Klionsky DJ. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 2007;8:931-937.
12. Kihara A, Kabeya Y, Ohsumi Y, et al. Beclin-phospha-tidylinositol 3-kinase complex functions at the trans-Golgi network. EMBO Rep 2001;2:330-335.
13. Kabeya Y, Mizushima N, Ueno T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 2000;19:5720-5728.
14. Noda T, Fujita N, Yoshimori T. The late stages of autophagy: how does the end begin? Cell Death Differ 2009;16:984-990.
15. Liao XH, Majithia A, Huang X, et al. Growth control via TOR kinase signaling, an intracellular sensor of amino acid and energy availability, withcrosstalk potential to proline metabolism. Amino Acids 2008;35:761-770.
16. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008;132:27-42.
17. Eisenberg-Lerner A, Bialik S, Simon HU, et al. Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ 2009; 16:966-975.
18. He C, Levine B. The beclin 1 interactome. Curr Opin Cell Biol 2010;22:140-149.
19. Morselli E, Galluzzi L, Kepp O, et al. Anti-and pro-tumor functions of autophagy. Biochim Biophys Acta 2009;1793:1524-1532.
20. Apel A, Zentgraf H, Büchler MW, et al. Autophagy-A double-edged sword in oncology. Int J Cancer 2009;125:991-995.
21. Kondo Y, Kanzawa T, Sawaya R, et al. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 2005;5:726-734.
22. Amaravadi RK, Yu D, Lum JJ, et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 2007;117:326-336.
23. Trincheri NF, Follo C, Nicotra G, et al. Resveratrol-induced apoptosis depends on the lipid kinase activity of Vps34 and on the formation of autophagolysosomes. Carcinogenesis 2008;29:381-389.
24. Shingu T, Fujiwara K, Bögler O, et al. Inhibition of autophagy at a late stage enhances imatinib-induced cytotoxicity in human malignant glioma cells. Int J Cancer 2009;124:1060-1071.
25. Li C, Capan E, Zhao Y, et al. Autophagy is induced in CD4+ T cells and important for the growth factor-withdrawal cell death. J Immunol 2006;177: 5163-5168.
26. Pua HH, Dzhagalov I, Chuck M, et al. A critical role for the autophagy gene Atg5 in T cell survival and proliferation. J Exp Med 2007;204:25-31.
27. Arsov I, Li X, Matthews G, et al. BAC-mediated transgenic expression of fluorescent autophagic protein beclin 1 reveals a role for beclin 1 in lymphocyte development. Cell Death Differ 2008;15:1385-1395.
28. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999;17:3835-3849.
29. Castino R, Peracchio C, Salini A, et al. Chemotherapy drug response in ovarian cancer cells strictly depends on a cathepsin D-Bax activation loop. J Cell Mol Med 2009;13:1096-1109.
30. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53: 457-481.
31. Pileri SA, Ascani S, Sabattini E, et al. The pathologist's view point. Part I indolent lymphomas. Haematologica 2000a;85:1291-1307. (Pubitemid 32063700)
32. Pileri SA, Ascani S, Sabattini E, et al. The pathologist's view point. Part II-aggressive lymphomas. Haemato-logica 2000b;85:1308-1321. (Pubitemid 32063701)
33. Itakura E, Mizushima N. Atg14 and UVRAG: mutually exclusive subunits of mammalian Beclin 1-PI3K complexes. Autophagy 2009;5:534-536.
34. Proikas-Cezanne T, Pfisterer SG. Assessing mammalian autophagy by WIPI-1/Atg18 puncta formation. Methods Enzymol 2009;452:247-260.
35. Adams JM, Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 2007;26: 1324-1337.
36. Levine B, Sinha S, Kroemer G. Bcl-2 family members: dual regulators of apoptosis and autophagy. Autop-hagy 2008;4:600-606.
37. Pattingre S, Tassa A, Qu X, et al. Bcl-2 antiapoptotic proteins inhibit beclin 1-dependent autophagy. Cell 2005;122:927-939.
38. Saeki K, Yuo A, Okuma E, et al. Bcl-2 down-regulation causes autophagy in a caspase-independent manner in human leukemic HL60 cells. Cell Death Differ 2000;7:1263-1269.
39. Scarlatti F, Maffei R, Beau I, et al. Role of non-canonical beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells. Cell Death Differ 2008;15:1318-1329.
40. Witzig TE, Geyer SM, Ghobrial I, et al. Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma. J Clin Oncol 2005; 23:5347-5356.
41. Yazbeck VY, Buglio D, Georgakis GV, et al. Temsir-olimus downregulates p21 without altering cyclin D1 expression and induces autophagy and synergizes with vorinostat in mantle cell lymphoma. Exp Hematol 2008;36:443-450.
42. Maclean KH, Dorsey FC, Cleveland JL, et al. Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis. J Clin Invest 2008;118:79-88.
43. Carew JS, Nawrocki ST, Kahue CN, et al. Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. Blood 2007;110: 313-322.